A 13-year-old girl in Canada became so sick with H5N1, or bird flu, in late 2024 that she had to be put on a ventilator.
In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...
Hosted on MSN2h
Is there a vaccine for H5N1? What we know as first person with severe case of bird flu died in United StatesThe H5N1 bird flu has been reported to have caused the death of a patient in Louisiana. Such a case poses a significant ...
Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent, tissue-targeted medicines, today ...
The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...
Drugmaker GSK said, a stamp has been released by India Post to commemorate its 100 years in India. The ₹5 denomination stamp ...
RNA is a long, polymeric molecule, composed of four different building blocks called nucleotides. In the last decade mRNA has progressed into a promising new class of medicine, with the potential to ...
GlaxoSmithKline ( (GSK) ) has provided an update.Don't Miss Our New Year's Offers:Discover the latest stocks recommended by top Wall Street ...
The co-developer of a US-approved drug, Professor Andrew Wilks has formed Synthesis Bioventures to sniff out more winners.
Monoclonal Antibodies IndustryThe global monoclonal antibodies (mAbs) industry, valued at USD 186 billion in 2021, is ...
Birmingham-based global coaching and training business, OTD, has announced the appointment of Rebecca Farnworth as managing ...
The "Global Big Pharma Partnering Terms and Agreements 2020-2024" report has been added to ResearchAndMarkets.com's offering.Global Big Pharma Partnering Terms and Agreements 2020 to 2024 report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback